125 related articles for article (PubMed ID: 9707500)
1. Monocrotaline pyrrole induces apoptosis in pulmonary artery endothelial cells.
Thomas HC; Lamé MW; Dunston SK; Segall HJ; Wilson DW
Toxicol Appl Pharmacol; 1998 Aug; 151(2):236-44. PubMed ID: 9707500
[TBL] [Abstract][Full Text] [Related]
2. Cell cycle alterations associated with covalent binding of monocrotaline pyrrole to pulmonary artery endothelial cell DNA.
Thomas HC; Lamé MW; Wilson DW; Segall HJ
Toxicol Appl Pharmacol; 1996 Nov; 141(1):319-29. PubMed ID: 8917705
[TBL] [Abstract][Full Text] [Related]
3. Monocrotaline pyrrole interacts with actin and increases thrombin-mediated permeability in pulmonary artery endothelial cells.
Wilson DW; Lamé MW; Dunston SK; Taylor DW; Segall HJ
Toxicol Appl Pharmacol; 1998 Sep; 152(1):138-44. PubMed ID: 9772209
[TBL] [Abstract][Full Text] [Related]
4. Procoagulant and fibrinolytic properties of bovine endothelial cells treated with monocrotaline pyrrole.
Schultze AE; Roth RA
Toxicol Appl Pharmacol; 1993 Sep; 122(1):7-15. PubMed ID: 8378934
[TBL] [Abstract][Full Text] [Related]
5. Prolonged cell-cycle arrest associated with altered cdc2 kinase in monocrotaline pyrrole-treated pulmonary artery endothelial cells.
Thomas HC; Lamé MW; Morin D; Wilson DW; Segall HJ
Am J Respir Cell Mol Biol; 1998 Jul; 19(1):129-42. PubMed ID: 9651189
[TBL] [Abstract][Full Text] [Related]
6. The response of pulmonary vascular endothelial cells to monocrotaline pyrrole: cell proliferation and DNA synthesis in vitro and in vivo.
Lappin PB; Ross KL; King LE; Fraker PJ; Roth RA
Toxicol Appl Pharmacol; 1998 May; 150(1):37-48. PubMed ID: 9630451
[TBL] [Abstract][Full Text] [Related]
7. DNA damage cell checkpoint activities are altered in monocrotaline pyrrole-induced cell cycle arrest in human pulmonary artery endothelial cells.
Wilson DW; Lamé MW; Dunston SK; Segall HJ
Toxicol Appl Pharmacol; 2000 Jul; 166(2):69-80. PubMed ID: 10896848
[TBL] [Abstract][Full Text] [Related]
8. Effects of monocrotaline pyrrole on cultured rat pulmonary endothelium.
Hoorn CM; Wagner JG; Roth RA
Toxicol Appl Pharmacol; 1993 Jun; 120(2):281-7. PubMed ID: 8511798
[TBL] [Abstract][Full Text] [Related]
9. Comparative cytotoxicity of monocrotaline and its metabolites in cultured pulmonary artery endothelial cells.
Taylor DW; Wilson DW; Lamé MW; Dunston SD; Jones AD; Segall HJ
Toxicol Appl Pharmacol; 1997 Mar; 143(1):196-204. PubMed ID: 9073608
[TBL] [Abstract][Full Text] [Related]
10. Lactate dehydrogenase activity and isozyme patterns in tissues and bronchoalveolar lavage fluid from rats treated with monocrotaline pyrrole.
Schultze AE; Gunaga KP; Wagner JG; Hoorn CM; Moorehead WR; Roth RA
Toxicol Appl Pharmacol; 1994 Jun; 126(2):301-10. PubMed ID: 8209383
[TBL] [Abstract][Full Text] [Related]
11. The effects of monocrotaline pyrrole on cultured bovine pulmonary artery endothelial and smooth muscle cells.
Reindel JF; Roth RA
Am J Pathol; 1991 Mar; 138(3):707-19. PubMed ID: 2000943
[TBL] [Abstract][Full Text] [Related]
12. Excess l-arginine restores endothelium-dependent relaxation impaired by monocrotaline pyrrole.
Cheng W; Oike M; Hirakawa M; Ohnaka K; Koyama T; Ito Y
Toxicol Appl Pharmacol; 2005 Sep; 207(3):187-94. PubMed ID: 16129112
[TBL] [Abstract][Full Text] [Related]
13. Monocrotaline pyrrole targets proteins with and without cysteine residues in the cytosol and membranes of human pulmonary artery endothelial cells.
Lamé MW; Jones AD; Wilson DW; Segall HJ
Proteomics; 2005 Nov; 5(17):4398-413. PubMed ID: 16222722
[TBL] [Abstract][Full Text] [Related]
14. Monocrotaline pyrrole-induced changes in angiotensin-converting enzyme activity of cultured pulmonary artery endothelial cells.
Hoorn CM; Roth RA
Br J Pharmacol; 1993 Oct; 110(2):597-602. PubMed ID: 8242234
[TBL] [Abstract][Full Text] [Related]
15. Characterization of monocrotaline pyrrole-induced DNA cross-linking in pulmonary artery endothelium.
Wagner JG; Petry TW; Roth RA
Am J Physiol; 1993 May; 264(5 Pt 1):L517-22. PubMed ID: 8498528
[TBL] [Abstract][Full Text] [Related]
16. Comparison of response of bovine and porcine pulmonary arterial endothelial cells to monocrotaline pyrrole.
Reindel JF; Hoorn CM; Wagner JG; Roth RA
Am J Physiol; 1991 Dec; 261(6 Pt 1):L406-14. PubMed ID: 1767861
[TBL] [Abstract][Full Text] [Related]
17. Monocrotaline pyrrole alters DNA, RNA and protein synthesis in pulmonary artery endothelial cells.
Hoorn CM; Roth RA
Am J Physiol; 1992 Jun; 262(6 Pt 1):L740-7. PubMed ID: 1377453
[TBL] [Abstract][Full Text] [Related]
18. Effect of monocrotaline metabolites on glutathione levels in human and bovine pulmonary artery endothelial cells.
Reid MJ; Dunston SK; Lamé MW; Wilson DW; Morin D; Segall HJ
Res Commun Mol Pathol Pharmacol; 1998 Jan; 99(1):53-68. PubMed ID: 9523355
[TBL] [Abstract][Full Text] [Related]
19. Golgi, trafficking, and mitosis dysfunctions in pulmonary arterial endothelial cells exposed to monocrotaline pyrrole and NO scavenging.
Lee J; Reich R; Xu F; Sehgal PB
Am J Physiol Lung Cell Mol Physiol; 2009 Oct; 297(4):L715-28. PubMed ID: 19648287
[TBL] [Abstract][Full Text] [Related]
20. Fibrinolytic activity in blood and lungs of rats treated with monocrotaline pyrrole.
Schultze AE; Roth RA
Toxicol Appl Pharmacol; 1993 Jul; 121(1):129-37. PubMed ID: 7687795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
